Moreover, using protein-based quantification of COL10A1 in tumor specimens based on histological staining and semi-quantitative signal quantification in 197 CRC patients, they identified the significant clinical negative prognostic value of an elevation of the biomarker. The gene discussed is COL10A1; the disease is neoplasm.